Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The price the NHS pays for US medicines could soar under a trade deal with the United States after the UK leaves the European Union, according to an investigation.
Despite Boris Johnson’s assertion that the NHS is not on the table, sources with knowledge of the initial trade discussions between the two countries question whether the Prime Minister is able to keep to that promise. In fact “drug pricing” has been discussed in six initial meetings between trade officials from the two countries and secret meetings between US drugs firms and British civil servants where medicine “price caps” have been talked about, according to Dispatches.
The programme, broadcast on Channel 4 on Monday night, was also told that British trade officials have been warned that the subject is so sensitive that they must not mention “drug pricing” in emails but use the term “valuing innovation”.
https://inews.co.uk/news/health/nhs-drugs-cost-brexit-trade-deal-usa-820816
Orwellian doublespeak
Despite Boris Johnson’s assertion that the NHS is not on the table, sources with knowledge of the initial trade discussions between the two countries question whether the Prime Minister is able to keep to that promise. In fact “drug pricing” has been discussed in six initial meetings between trade officials from the two countries and secret meetings between US drugs firms and British civil servants where medicine “price caps” have been talked about, according to Dispatches.
The programme, broadcast on Channel 4 on Monday night, was also told that British trade officials have been warned that the subject is so sensitive that they must not mention “drug pricing” in emails but use the term “valuing innovation”.
https://inews.co.uk/news/health/nhs-drugs-cost-brexit-trade-deal-usa-820816
Orwellian doublespeak